![]() were the first to report on this syndrome as a distinct clinical entity. Contralateral axillary nodal metastases: Stage IV disease or a manifestation of progressive locally advanced breast cancer? 2021.In the past, several terms have been used to refer to patients with spontaneous, atraumatic swelling of the left supraclavicular fossa, including ‘benign supraclavicular tumorous lymphangiectasia’ and ‘recurrent lymphangiectasia of the left supraclavicular fossa’. Comparison of survival outcomes among patients with breast cancer with distant vs ipsilateral supraclavicular lymph node metastases. The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemma. Contralateral axillary lymph node metastases from breast carcinoma: Is it time to review TNM cancer staging? Ann Surg Oncol. Contralateral lymph node recurrence in breast cancer: Regional event rather than distant metastatic disease. Moossdorff M, Vugts G, Maaskant-Braat AJG, et al. Contralateral axillary nodal involvement from invasive breast cancer. Kiluk JV, Prowler V, Lee MC, Khakpour N, Laronga C, Cox CE. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma. Contralateral axillary metastases in breast cancer: Stage IV disease or a locoregional event? Am Surg. Guru SD, Loprinzi CL, Yan E, Hoskin TL, Jakub JW. Isolated contralateral axillary lymph node involvement in breast cancer represents a locally advanced disease not distant metastases. 2018.Ĭhkheidze R, Sanders MG, Haley B, Leitch AM, Sahoo S. 2011 37:418–21.Īmin MB (eds) AJCC Cancer Staging Manual, 8th Edition. Characteristics of and therapeutic options for contralateral axillary lymph node metastasis in breast cancer. Outcomes of positron emission tomography-staged clinical N3 breast cancer treated with neoadjuvant chemotherapy, surgery, and radiotherapy. A retrospective study of metachronous and synchronous ipsilateral supraclavicular lymph node metastases in breast cancer patients. Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. Breast cancer with ipsilateral supraclavicular metastases. Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer. Impact of ipsilateral supraclavicular lymph node dissection (ISLND) for breast cancer patients and a nomogram for predicting ipsilateral supraclavicular pathological complete response (ispCR). Comparison between surgery plus radiotherapy and radiotherapy alone in treating breast cancer patients with ipsilateral supraclavicular lymph node metastasis. Sun X, Wang Y, Huang T, Niu L, Zhang Q, Liu Z. Supraclavicular lymph node dissection with radiotherapy versus radiotherapy alone for operable breast cancer with synchronous ipsilateral supraclavicular lymph node metastases: a real-world cohort study. Treatment patterns and outcomes of women with breast cancer and supraclavicular nodal metastases. Contemporary outcomes after multimodality therapy in patients with breast cancer presenting with ipsilateral supraclavicular node involvement. ![]() Staging system for breast cancer: revisions for the 6th edition of the AJCC cancer staging manual. ![]() Singletary SE, Allred C, Bassett LW, et al. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: the University of Texas M.D. 2020.īrito RA, Valero V, Buzdar AU, et al. Surgery of the primary tumor offers survival benefits of breast cancer with synchronous ipsilateral supraclavicular lymph node metastasis.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |